vs
La Rosa Holdings Corp.（LRHC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是La Rosa Holdings Corp.的1.8倍（$35.5M vs $20.2M），La Rosa Holdings Corp.净利率更高（-27.4% vs -304.2%，领先276.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.2%），过去两年La Rosa Holdings Corp.的营收复合增速更高（72.5% vs 60.5%）
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LRHC vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.8倍
$20.2M
营收增速更快
RXRX
高出678.6%
3.2%
净利率更高
LRHC
高出276.9%
-304.2%
两年增速更快
LRHC
近两年复合增速
60.5%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.2M | $35.5M |
| 净利润 | $-5.5M | $-108.1M |
| 毛利率 | 8.4% | 59.8% |
| 营业利润率 | -24.7% | -304.8% |
| 净利率 | -27.4% | -304.2% |
| 营收同比 | 3.2% | 681.7% |
| 净利润同比 | -125.7% | 39.6% |
| 每股收益（稀释后） | $-5.44 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LRHCRXRX
| Q4 25 | — | $35.5M | ||
| Q3 25 | $20.2M | $5.2M | ||
| Q2 25 | $23.2M | $19.2M | ||
| Q1 25 | $17.5M | $14.7M | ||
| Q4 24 | $17.7M | $4.5M | ||
| Q3 24 | $19.6M | $26.1M | ||
| Q2 24 | $19.1M | $14.4M | ||
| Q1 24 | $13.1M | $13.8M |
净利润LRHCRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-5.5M | $-162.3M | ||
| Q2 25 | $78.4M | $-171.9M | ||
| Q1 25 | $-95.7M | $-202.5M | ||
| Q4 24 | $-5.1M | $-178.9M | ||
| Q3 24 | $-2.5M | $-95.8M | ||
| Q2 24 | $-2.3M | $-97.5M | ||
| Q1 24 | $-4.6M | $-91.4M |
毛利率LRHCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | 8.4% | -183.8% | ||
| Q2 25 | 8.0% | -4.9% | ||
| Q1 25 | 8.8% | -48.0% | ||
| Q4 24 | 8.9% | -181.4% | ||
| Q3 24 | 8.3% | 53.7% | ||
| Q2 24 | 8.3% | 36.2% | ||
| Q1 24 | 8.9% | 19.1% |
营业利润率LRHCRXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -24.7% | -3327.6% | ||
| Q2 25 | -10.6% | -916.8% | ||
| Q1 25 | -26.7% | -1297.9% | ||
| Q4 24 | -17.1% | -4042.4% | ||
| Q3 24 | -8.9% | -377.1% | ||
| Q2 24 | -9.7% | -697.4% | ||
| Q1 24 | -35.0% | -698.4% |
净利率LRHCRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -27.4% | -3135.3% | ||
| Q2 25 | 337.8% | -894.2% | ||
| Q1 25 | -546.5% | -1373.3% | ||
| Q4 24 | -28.7% | -3935.5% | ||
| Q3 24 | -12.5% | -367.5% | ||
| Q2 24 | -12.2% | -676.6% | ||
| Q1 24 | -35.1% | -662.4% |
每股收益（稀释后）LRHCRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-5.44 | $-0.36 | ||
| Q2 25 | $15.25 | $-0.41 | ||
| Q1 25 | $-5.86 | $-0.50 | ||
| Q4 24 | $28.54 | $-0.56 | ||
| Q3 24 | $-16.49 | $-0.34 | ||
| Q2 24 | $-12.49 | $-0.40 | ||
| Q1 24 | $-0.35 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $743.3M |
| 总债务越低越好 | $642.8K | $9.6M |
| 股东权益账面价值 | $1.6M | $1.1B |
| 总资产 | $21.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.41× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LRHCRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $4.0M | $659.8M | ||
| Q2 25 | $5.1M | $525.1M | ||
| Q1 25 | $2.9M | $500.5M | ||
| Q4 24 | $1.4M | $594.4M | ||
| Q3 24 | $1.8M | $427.6M | ||
| Q2 24 | $1.6M | $474.3M | ||
| Q1 24 | $1.1M | $296.3M |
总债务LRHCRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | $642.8K | $11.9M | ||
| Q2 25 | $644.3K | $14.2M | ||
| Q1 25 | $645.9K | $16.4M | ||
| Q4 24 | $647.6K | $19.0M | ||
| Q3 24 | $649.2K | $20.5M | ||
| Q2 24 | $650.8K | $22.9M | ||
| Q1 24 | $652.4K | — |
股东权益LRHCRXRX
| Q4 25 | — | $1.1B | ||
| Q3 25 | $1.6M | $1.0B | ||
| Q2 25 | $3.4M | $919.1M | ||
| Q1 25 | $-87.5M | $933.9M | ||
| Q4 24 | $2.6M | $1.0B | ||
| Q3 24 | $5.0M | $524.6M | ||
| Q2 24 | $4.7M | $584.4M | ||
| Q1 24 | $5.6M | $401.2M |
总资产LRHCRXRX
| Q4 25 | — | $1.5B | ||
| Q3 25 | $21.7M | $1.4B | ||
| Q2 25 | $22.9M | $1.3B | ||
| Q1 25 | $21.0M | $1.3B | ||
| Q4 24 | $19.4M | $1.4B | ||
| Q3 24 | $19.7M | $726.5M | ||
| Q2 24 | $18.7M | $775.9M | ||
| Q1 24 | $16.3M | $557.8M |
负债/权益比LRHCRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.41× | 0.01× | ||
| Q2 25 | 0.19× | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.25× | 0.02× | ||
| Q3 24 | 0.13× | 0.04× | ||
| Q2 24 | 0.14× | 0.04× | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LRHCRXRX
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $-1.3M | $-117.4M | ||
| Q2 25 | $-1.4M | $-76.4M | ||
| Q1 25 | $-3.5M | $-132.0M | ||
| Q4 24 | $-1.1M | $-115.4M | ||
| Q3 24 | $-591.6K | $-59.2M | ||
| Q2 24 | $-803.1K | $-82.2M | ||
| Q1 24 | $-538.3K | $-102.3M |
自由现金流LRHCRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率LRHCRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度LRHCRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率LRHCRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
RXRX
暂无分部数据
